| Literature DB >> 30123008 |
Zahra Behboodi Moghadam1, Bita Fereidooni2, Mohsen Saffari3, Ali Montazeri4.
Abstract
INTRODUCTION: Polycystic ovary syndrome (PCOS) is associated with biochemical and hormonal disturbance and adverse cosmetic, reproductive, metabolic, and psychological consequences, resulting in reduced health-related quality of life (HRQoL). Various generic and specific questionnaires have been used for assessing different dimensions of HRQoL in PCOS women. The purpose of this systematic review was to identify those general and specific instruments and to determine the factors that affect HRQoL in PCOS women.Entities:
Keywords: health-related quality of life; polycystic ovary syndrome; questionnaires; systematic review
Year: 2018 PMID: 30123008 PMCID: PMC6078086 DOI: 10.2147/IJWH.S165794
Source DB: PubMed Journal: Int J Womens Health ISSN: 1179-1411
Figure 1The flow diagram of the review.
Quantitative studies that measured HRQoL of women with PCOS (n=43)
| Study; country | Design | Objective | Diagnosis criteria | Age (years, mean ± SD) | HRQoL instruments used | Sample size | Main outcomes |
|---|---|---|---|---|---|---|---|
| Cronin et al; | Cross-sectional | Designing tools for measuring the QoL in women with PCOS | NIH | 18–45 | PCOSQ | 100 PCOS; 12 interviews | Developing PCOSQ, which includes 26 items |
| Wong et al; | Cross-sectional | Examining the relative impact of the number and severity of patient problems on HRQoL | Not stated | 30.5±6.7 | PCOSQ | 100 | Including all potential items in calculating a domain score provided a more accurate portrait of HRQoL |
| Trent et al; | Cross-sectional | Evaluating the HRQoL in adolescents with PCOS and its correlation with patients’ perception | NIH | 13–22 | CHQ-CF87 | 146 control, 97 PCOS | Patients had worsened QoL. Patients with higher self-perceived severity scored were lower on the general health perception |
| Trent et al; | Cross-sectional | Evaluating the fertility concerns and sexual behavior in young PCOS women compared with healthy women | NIH | 13–22 | CHQ-CF87 | 146 control, 97 PCOS | PCOS women were 3.4 times more likely to be worried about fertility issues |
| Elsenbruch et al; | Case–control | Evaluating the quality of life, mental status, and sexual satisfaction in PCOS women | NIH | Controls: 29.9±5.7; PCOS: 28.4±5.0 | SF-36, SCL-90-R | 50 control, 50 PCOS | PCOS caused a major reduction in the QoL and severely limits sexual satisfaction |
| Hashimoto et al; | Case–control | Evaluating the impact of weight status on symptom perception and QoL in PCOS women with different background | NIH | Brazilian: 25.5±3.9; Austrian: 23.8±4.7 | PCOSQ | 50 control, 50 PCOS | In Brazilian women, hirsutism and in Austria obesity had the greatest impact on QoL |
| Guyatt et al; | Cross-sectional | Measuring the psychometric properties of the PCOSQ | NIH | 29.4±5.7 | PCOSQ | 393 | Factor analysis provided moderate to strong support for the 5-domain structure of the PCOSQ |
| Schmid et al; | Cross-sectional | Study of infertile PCOS patients QoL with different ethnic and cultural backgrounds | Not stated | 18–39 | PCOSQ | 14 Muslim, 35 Austrian PCOS | HRQoL of women with an Islamic background was affected to a greater degree than that of Austrian women |
| Jones et al; | Cross-sectional | Measuring the psychometric properties of the PCOSQ | NIH | – | PCOSQ, SF-36 | 92 | The PCOSQ is a reliable instrument for measuring the HRQoL |
| Van Wely et al; | Interventional | Evaluating the impact of laparoscopic electrocautery of the ovaries versus recombinant FSH on the PCOS patients’ HRQoL | Rotterdam | Electrocautery: 28.5±3.7; FSH: 28.7±4.1 | SF-36 | Electrocautery: 83, FSH: 85 | HRQoL was not affected in both groups. FSH treatment was slightly more burdensome for women’s HRQoL than electrocautery |
| Clayton et al; | Interventional | Evaluation the effect of laser on the severity of facial hirsutism and on psychological complications in PCOS women | Not stated | PCOS: 33.0±8.0; control: 32±6.5 | WHOQOL-BREF | 37 control, 51 intervention | Laser treatment reduced the severity of facial hair as well as alleviating depression and anxiety in patients |
| McCook et al; | Cross-sectional | Evaluating the influence of the major clinical features of PCOS on patients’ QoL | Not stated | 20–41 | PCOSQ | 128 | The most common HRQoL concern reported by women with PCOS was weight. BMI and fertility loss had the greater impact on QoL |
| Trent et al; | Cross-sectional | Assessing the BMI impact on the QoL of adolescents with PCOS | NIH | 13–22 | CHQ-CF87 | 146 control, 97 PCOS | BMI is a primary mediator in the relationship between PCOS and HRQoL reductions |
| Hahn et al; | Case–control | Examining the extent of different PCOS manifestations on QoL, psychosocial well- being, and sexual satisfaction | NIH | PCOS: 29.0±5.4; control: 30.0±5.7 | SF-36, SCL-90-R | 120 control, 50 PCOS | PCOS patients showed significant reductions in QoL, psychosocial well-being, and sexual satisfaction |
| Elsenbruch et al; | Cross-sectional | Evaluation of psychological stress in untreated PCOS patients and to assess the impact of emotional distress on QoL | NIH | 31.3±1.3 | SF-36, SCL-90-R | 143 | Majority of patients exhibited psychological disturbances. Emotional distress together with obesity leads to large decrements in QoL |
| Lipton et al; | Cross-sectional | Assessing the behavioral and psychological burden of facial hair in PCOS women | Not stated | 33.0±7.4 | WHOQOL-BREF | 88 | Facial hair carries a high psychological burden for women. 29% of patients reported depression and anxiety |
| Coffey et al; | Case–control | Comparing the QoL in women with PCOS with the general population and patients with other medical conditions | AES | PCOS: 27.5; control: 28.8 | SF-36, PCOSQ | 22 control, 96 PCOS | PCOS had a negative impact on HRQoL even when compared with other medical conditions (asthma, epilepsy, diabetes, arthritis, and coronary heart disease) |
| Hahn et al; | Interventional | Evaluation the effects of metformin treatment on HRQoL, emotional well-being, and sexuality in PCOS women | NIH Rotterdam | 29.3±6.3 | SF-36, SCL-90-R | 327 | Treatment improved the psychosocial, emotional, and psychosexual situation of PCOS patients |
| Barnard et al; | Cross-sectional | Assessing the quality of life of women with PCOS, studying the factor analysis and adding acne factor | Rotterdam | 31.0±6.5 | MPCOSQ | 935 control, 424 PCOS | The PCOSQ was modified to include acne. The PCOS groups had significantly worse QoL than controls |
| Drosdzol et al; | Case–control | To evaluate the effect of PCOS on QoL and marital sexual satisfaction | Rotterdam | 19–40 | SF-36 | 40 control, 50 PCOS | PCOS decreased QoL and sexual functioning among women. A negative effect of hirsutism severity on general well- being and sexual life was also observed |
| Ching et al; | Case–control | Evaluation of QoL and psychological complications in PCOS women, compared the findings with general norms | NIH | PCOS: 15–65; control 18–44 | SF-36, PCOSQ, GHQ-28 | 173 control, 203 PCOS | Impaired QoL and increased prevalence of psychological morbidity in PCOS compared with population norms were obtained |
| Tan et al; | Cross-sectional | Assessing the impact of infertility on various aspects of psychological function in PCOS women | NIH | 28.1±4.8 | SF-36, SCL-90-R | 115 | PCOS obtained a major risk factor for psychosocial and emotional problems. Infertility was not a primary determinant of psychological problems |
| Rofey et al; | Interventional | Evaluating cognitive–behavioral therapy on psychological problems of PCOS adolescents | AES | 12–18 | SF-36 | 25 | Depressive symptoms and weight decreased significantly |
| Harris-Glocker et al; | Interventional | Assessing the effect of treatment (metformin, lifestyle) on the QoL in obese PCOS adolescents | NIH | 12–18 | PCOSQ | 36 | QoL was improved in both groups (lifestyle and obsessive–compulsive disorder treatment) |
| Ladson et al; | Interventional | Assessing the effect of treatment (metformin, lifestyle) on the QoL of adolescents with PCOS | NIH | 13–18 | PCOSQ | 28 | QoL was significantly improved in both treatment groups |
| Moran et al; | Case–control | Evaluating the psychological features in young girl with PCOS compared with healthy women | Rotterdam | 18–25 | PCOSQ | 22 control, 24 PCOS | Worsened QoL in PCOS women |
| Thomson et al; | Interventional | Assessing the effect of exercise and dietary restriction on depressive symptoms and HRQoL in obese women with PCOS | Rotterdam | 29.3±0.7 | PCOSQ | 104 | Dietary restriction, with/without exercise, had similar benefits for improving depression and HRQoL in obese women with PCOS |
| Ladson et al; | Interventional | Determining the effect of lifestyle changes (caloric restriction and exercise) on the QoL of PCOS women | NIH | 29.0±4.5 | PCOSQ | 114 | QoL was improved in emotion and weight areas within each treatment group |
| Bazarganipour et al; | Cross-sectional | Assessing the prevalence of mood disorders and examine predictors for psychological well-being among Iranian PCOS women | Rotterdam | 15–40 | SF-36 | 300 | 32% of patients showed elevated anxiety and depression. QoL was very impaired in women with anxiety and depression |
| Bazarganipour et al; | Cross-sectional | Evaluating the effect of different clinical symptoms of PCOS on patients HRQoL | Rotterdam | 15–40 | MPCOSQ | 200 | Worsened HRQoL in PCOS women was related to more menstrual problems and infertility than to obesity |
| Stener-Victorin et al; | Interventional | The effect of exercise and acupuncture on the QoL in PCOS women | Rotterdam | 29.9±4.4 | SF-36, PCOSQ | 114 | Anxiety and depression improved in women treated with acupuncture. HRQoL was improved in both groups |
| Bazarganipour et al; | Cross-sectional | Determining the association between HRQoL and psychosexual variables in patients with PCOS | Rotterdam | 15–40 | MPCOSQ | 300 | The highest effect of PCOS symptoms on HRQoL was exerted by clinical variables, poor perception, negative body image, and sexual dysfunction |
| De Frène et al; | Cross-sectional | Investigating the relationship between PCOS symptoms with sexual and relational satisfaction in obese women and their partners | Rotterdam | 18–43 | PCOSQ | 62 | PCOS characteristics and its concerns were associated with the sexual and/or relational satisfaction of couples |
| McCook et al; | Cross-sectional | Investigating the relative contributions of PCOS manifestations to psychological symptoms | Rotterdam | 18–48 | PCOSQ | 126 | Patients were at a greater risk for depression, anxiety, and interpersonal sensitivity. Menstrual problems predicted every dimension of psychological distress |
| Benetti-Pinto et al; | Case–control | Assessing the sexual function and QoL in PCOS women | Rotterdam | PCOS: 26.9±4.9; control: 35.6±7.3 | WHOQOL-BREF | 102 control, 56 PCOS | PCOS women had a worse sexual function and worse QoL in the self-assessment of the health area. Obesity was correlated to the worsening in QoL |
| Guidi et al; | Cross-sectional | Assessing the psychosocial effects of PCOS on adolescents | NIH | 16–19 | PCOSQ | 394 | Impaired well-being and QoL were found among young females with PCOS |
| Stefanaki et al; | Interventional | The effect of mindfulness – stress program on mental status and QoL in PCOS women | Rotterdam | 15–40 | PCOSQ | 73 | Stress, anxiety, and depression levels decreased and QoL improved |
| Nasiri-Amiri et al; | Mixed methods | Designing HRQoL measurement tool in Iranian women with PCOS | Rotterdam | 18–40 | PCOSQ-50 | 200 PCOS, 23 interviews | The PCOSQ-50 was a valid and reliable instrument for the assessment of QoL of women with PCOS |
| Shishehgar et al; | Case–control | Comparing the effects of obesity on the HRQoL between women with PCOS and controls | AES | PCOS: 28.6±4.9; control: 29.0±5.8 | SF-36 | 140 control, 142 PCOS | The physical aspects of HRQoL were adversely affected by obesity in both groups, but these impaired effects were greater in PCOS group |
| Huang-TzOu et al; | Interventional | Effect of metformin on the QoL of women with PCOS | Rotterdam | 18–45 | WHOQOL-BREF, PCOSQ | 109 | Metformin improved HRQoL of PCOS women especially in overweight patients |
| Dokras et al; | Interventional | Evaluation of the effect of weight loss on mood disorders and QoL in obese women with PCOS | Rotterdam | 18–40 | SF-36, PCOSQ | 149 | Weight loss result in significant improvements in several physical and mental domains related to QoL |
| Ozcan Dag et al; | Case–control | Assessment of temperament and QoL in PCOS patients | Rotterdam | PCOS: 22.6±4.5; control: 21.3±2.1 | SF-36 | 38 control, 53 PCOS | PCOS patients had significantly higher rates of depressive and anxious compared with controls. QoL was significantly lower in patients |
| Panico et al; | Case–control | Comparing the QoL in obese and normal weight women with PCOS | Rotterdam | Controls: 16.4–31; PCOS: 17.2–29 | SF-36, PCOSQ, SCL-90-R | 80 control, 100 PCOS | Worsening of HRQoL in PCOS patients compared with controls |
Abbreviations: AES, Androgen Excess Society; BMI, body mass index; CHQ-CF87, Child Health Questionnaire-Child Form; FSH, follicle-stimulating hormone; GHQ-28, General Health Questionnaire-28; HRQoL, health-related quality of life; MPCOSQ, Modified PCOSQ; NIH, National Institutes of Health; PCOS, polycystic ovary syndrome; PCOSQ, Polycystic Ovary Syndrome Health-Related Quality of Life Questionnaire; PCOSQ-50, Polycystic Ovary Syndrome Questionnaire; QoL, quality of life; SCL-90-R, Symptom Checklist-90-Revised; SF-36, 36-Item Short Form Health Survey; WHOQOL-BREF, World Health Organization Quality-of-Life-BREF.
Different components of quality of life in PCOS women
| Dimensions | Studies |
|---|---|
| Psychological and emotional | McCook et al, |
| Body image | Trent et al, |
| Social | Trent et al, |
| Sexual | Elsenbruch et al, |
| Physical | |
| Weight | Barnard et al, |
| Hirsutism and acne | Elsenbruch et al, |
| Menstrual problem | Bazarganipour et al, |
| Infertility | Schmid et al, |
| Medical | Van Wely et al, |
Abbreviation: PCOS, polycystic ovary syndrome.
Most general and specific instruments for assessing HRQoL in women with PCOS
| Instruments | No of items | Dimensions covered | Studies |
|---|---|---|---|
| General instruments | |||
| SF-36 | 36 | Physical functioning, vitality/energy, physical role limitation, bodily pain, mental health, emotional role limitation, general health perception, and social functioning | Elsenbruch et al, |
| SCL-90-R | 90 | Somatization, obsessive–compulsive, interpersonal sensitivity, paranoid ideation, psychoticism, anxiety depression, phobia, and aggression | Elsenbruch et al, |
| CHQ-CF87 | 87 | Change in health in the last year, role/social emotional, behavioral, physical, bodily pain, behavior, mental health, self-esteem, general health perceptions, family activities, family cohesion, and physical functioning | Trent et al, |
| WHOQOL-BREF | 26 | General health, physical health, psychological, health, Social relationship, and environmental | Clayton et al, |
| GHQ-28 | 28 | Somatic symptom, anxiety/insomnia, social dysfunction, and depression | Ching et al |
| Specific instruments | |||
| PCOSQ | 26 | Emotion, hirsutism, infertility, weight, and menstrual problem | Cronin et al, |
| MPCOSQ | 30 | Emotion, hirsutism, infertility, weight, menstrual problem, and acne | Barnard et al, |
| PCOSQ-50 | 50 | Psychosocial and emotional, fertility, sexual, obesity, and menstrual disorders, hirsutism, and coping | Nasiri-Amiri et al |
Abbreviations: CHQ-CF87, Child Health Questionnaire-Child Form; GHQ-28, General Health Questionnaire-28; HRQoL, health-related quality of life; MPCOSQ, Modified PCOSQ; PCOS, polycystic ovary syndrome; PCOSQ, Polycystic Ovary Syndrome Health-Related Quality of Life Questionnaire; PCOSQ-50, Polycystic Ovary Syndrome Questionnaire; SCL-90-R, Symptom Checklist-90-Revised; SF-36, 36-Item Short Form Health Survey; WHOQOL-BREF, World Health Organization Quality-of-Life-BREF.